Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.21 -0.21 (-1.28%)
As of: Sep 30, 2026 · 10:14 AM EDT

Aurinia Pharmaceuticals (AUPH) EBIT Margin (2019 - 2026)

Updated

Aurinia Pharmaceuticals (AUPH) recorded EBIT Margin of 55.68% in Q2 2026, up 27.00 percentage points from 28.69% a year earlier and up 2.38 percentage points from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) EBIT Margin (2019 - 2026) Analysis & Trends

On a TTM basis, Aurinia Pharmaceuticals' EBIT Margin came in at 48.39% as of Jun 30, 2026, up 28.40 percentage points year-over-year; for FY2025, it came in at 37.06%, up 39.06 percentage points from FY2024.

  • Annual EBIT Margin has increased for four straight years, with a five-year change of +245.52 percentage points (FY2020 to FY2025).
  • Across earlier years, EBIT Margin came in at -1.99% in FY2024 (+50.25 pp), -52.24% in FY2023 (+30.93 pp), -83.17% in FY2022 (+313.14 pp) and -396.31% in FY2021 (-187.85 pp).
  • The Q2 2026 figure is the highest quarterly EBIT Margin in data going back to Q4 2019.
  • On a year-over-year basis, EBIT Margin has increased for 11 consecutive quarters, with an average year-over-year change of +39.65 percentage points over the last eight quarters.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 145570.48 percentage points in Q3 2021, against a drop of 123.65 percentage points in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at 53.31% (Q1 2026), 43.10% (Q4 2025) and 40.49% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Aurinia Pharmaceuticals 2.20 Bn 623.91 Mn 76.67 Mn 55.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.68%
Mar 31, 2026 53.31%
Dec 31, 2025 43.10%
Sep 30, 2025 40.49%
Jun 30, 2025 28.69%
Mar 31, 2025 34.97%
Dec 31, 2024 -2.79%
Sep 30, 2024 17.33%
Jun 30, 2024 -2.65%
Mar 31, 2024 -26.35%
Dec 31, 2023 -65.80%
Sep 30, 2023 -29.83%
Jun 30, 2023 -38.97%
Mar 31, 2023 -85.98%
Dec 31, 2022 -98.82%
Sep 30, 2022 -17.03%
Jun 30, 2022 -127.66%
Mar 31, 2022 -175.18%
Dec 31, 2021 -139.74%
Sep 30, 2021 -343.31%
API Access

Aurinia Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=AUPH&period=max&api_key=YOUR_API_KEY